BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19537896)

  • 1. Lack of association between serum transforming growth factor-beta 1 and cancer mortality risk in a nested case-control study in Japan.
    Lin Y; Nakachi K; Ito Y; Kikuchi S; Tamakoshi A; Yagyu K; Watanabe Y; Inaba Y; Tajima K;
    Asian Pac J Cancer Prev; 2009; 10(2):273-8. PubMed ID: 19537896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).
    Lin Y; Kikuchi S; Tamakoshi A; Obata Y; Yagyu K; Inaba Y; Kurosawa M; Kawamura T; Motohashi Y; Ishibashi T;
    Cancer Causes Control; 2006 Oct; 17(8):1077-82. PubMed ID: 16933058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of cases and controls for the nested case-control study within the Japan Collaborative Cohort Study: the First-wave.
    Tamakoshi A; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Ohno Y;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():1-5. PubMed ID: 20553075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Fas level and cancer mortality: findings from a nested case-control study within a large-scale prospective study.
    Tamakoshi A; Nakachi K; Ito Y; Lin Y; Yagyu K; Kikuchi S; Watanabe Y; Inaba Y; Tajima K;
    Int J Cancer; 2008 Oct; 123(8):1913-6. PubMed ID: 18688865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum levels of superoxide dismutase activity and subsequent risk of cancer mortality: Findings from a nested case-control study within the Japan Collaborative Cohort Study.
    Pham TM; Fujino Y; Nakachi K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Tamakoshi A; Yoshimura T;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():69-73. PubMed ID: 20553085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
    Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
    Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Plasma Transforming Growth Factor β1 Levels Predict the Development of Hypertension in Normotensives: The 14-Year Follow-Up Study.
    Nakao E; Adachi H; Enomoto M; Fukami A; Kumagai E; Nakamura S; Nohara Y; Kono S; Sakaue A; Morikawa N; Tsuru T; Fukumoto Y
    Am J Hypertens; 2017 Aug; 30(8):808-814. PubMed ID: 28575138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study.
    Yatsuya H; Tamakoshi A; Tamakoshi K; Hoshiyama Y; Fujino Y; Tokui N; Mizoue T; Kikuchi S; Sakata K; Hayakawa N; Kondo T; Toyoshima H; Yoshimura T
    Asian Pac J Cancer Prev; 2005; 6(2):170-6. PubMed ID: 16101328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble fas levels and superoxide dismutase activity and the risk of death from pancreatic cancer: A nested case-control study within the Japanese Collaborative Cohort Study.
    Lin Y; Kikuchi S; Yagyu K; Ishibashi T; Kurosawa M; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():81-5. PubMed ID: 20553087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
    Engels EA; Jennings L; Kemp TJ; Chaturvedi AK; Pinto LA; Pfeiffer RM; Trotter JF; Acker M; Onaca N; Klintmalm GB
    Cancer Med; 2015 Aug; 4(8):1252-7. PubMed ID: 25919050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults.
    Lin Y; Nakachi K; Ito Y; Kikuchi S; Tamakoshi A; Yagyu K; Watanabe Y; Inaba Y; Kazuo Tajima ;
    Dis Markers; 2009; 27(1):23-8. PubMed ID: 19822955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population.
    Kornitzer M; Valente F; De Bacquer D; Neve J; De Backer G
    Eur J Clin Nutr; 2004 Jan; 58(1):98-104. PubMed ID: 14679373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer mortality and serum levels of carotenoids, retinol, and tocopherol: a population-based follow-up study of inhabitants of a rural area of Japan.
    Ito Y; Kurata M; Hioki R; Suzuki K; Ochiai J; Aoki K
    Asian Pac J Cancer Prev; 2005; 6(1):10-5. PubMed ID: 15780024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
    Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antioxidants and subsequent mortality rates of all causes or cancer among rural Japanese inhabitants.
    Ito Y; Suzuki K; Suzuki S; Sasaki R; Otani M; Aoki K
    Int J Vitam Nutr Res; 2002 Jul; 72(4):237-50. PubMed ID: 12214561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of food and nutrient intakes with serum IGF-I, IGF-II, IGFBP-3, TGF-b1, total SOD activity and sFas levels among middle-aged Japanese: the Japan Collaborative Cohort study.
    Maruyama K; Iso H; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():7-22. PubMed ID: 20553076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor Beta 1 (TGF-β1) in Thyroid Cancer Patients: a View from the Peripheral Blood.
    Zivancevic-Simonovic S; Mihaljevic O; Mihajlovic D; Milosevic-Djordjevic O; Jovanovic Z; Mijatovic-Teodorovic L; Colic M
    Ann Clin Lab Sci; 2016 Jul; 46(4):401-6. PubMed ID: 27466300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib.
    Lin TH; Shao YY; Chan SY; Huang CY; Hsu CH; Cheng AL
    Clin Cancer Res; 2015 Aug; 21(16):3678-84. PubMed ID: 25977342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.